Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Rising Public Interest in Weight Loss Medications and Growing Awareness of Their Aesthetic Sequelae: An Infodemiologic Google Trends Analysis and Clinical Diagnostic Patterning

McCarthy AD., Durairaj K., Linneman-Heath J., Sajic D., Dacso M., Durkin A.

Laboratory Study on Face & Skin, published in J Cosmet Dermatol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Cosmet Dermatol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41521763
PMCID
PMC12793942
DOI
10.1111/jocd.70670
Citations
1

Abstract (original English)

Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have gained rapid popularity for both medical and consumer-directed weight loss. This growth has been accompanied by increased public discussion regarding facial aesthetic changes, commonly referred to as "Ozempic face," characterized by volume depletion and cutaneous laxity. Objective To quantify temporal patterns of public search interest in a widely known GLP-1 RA and evaluate corresponding awareness of its cosmetic facial sequelae using infodemiologic methods. Methods Google Trends data for "Ozempic" and related frequently co-searched queries were analyzed from November 2021 to December 2024. Trends in relative search volume (RSV) were examined, with particular focus on terms associated with facial aesthetics, including "Ozempic face" and "plastic surgeons Ozempic face." Results RSV for "Ozempic" showed a steady upward trajectory over the study period. Queries related to facial aesthetic consequences exhibited substantial proportional increases. Notably, "Ozempic face" demonstrated a 4600% rise in RSV, and searches for "plastic surgeons Ozempic face" similarly grew markedly. Conclusions Public interest in GLP-1 RAs is strongly associated with rising awareness and concern about their facial aesthetic effects. These trends suggest that aesthetic practitioners should expect more patient inquiries regarding GLP-1-

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
FaceHumansAnti-Obesity AgentsEstheticsInternetSearch EngineGlucagon-Like Peptide-1 Receptor AgonistsSemaglutide

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research